RxDoctor Payments Data

Michael Fox

Pulmonary Disease · Orange, CANPI 1053389254

Payments from drug & device makers

$1,897in general payments, 2019–2025

Across 116 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$420
  • AstraZeneca$231
  • Boehringer Ingelheim$219
  • AbbVie$155
  • Johnson & Johnson$132
  • Vanda Pharmaceuticals Inc.$90
  • plus $650 from 18 others

What the payments were for

  • Food & beverage$1,897100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,897 in reported general payments places this provider in the 50th percentile of 1,261 pulmonary disease providers in California.

See all pulmonary disease providers in California

Other pulmonary disease in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →